{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:16:21Z","timestamp":1790972181280,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,4,25]],"date-time":"2010-04-25T00:00:00Z","timestamp":1272153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1038\/nm.2122","type":"journal-article","created":{"date-parts":[[2010,4,25]],"date-time":"2010-04-25T18:38:35Z","timestamp":1272220715000},"page":"580-585","source":"Crossref","is-referenced-by-count":90,"title":["PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2"],"prefix":"10.1038","volume":"16","author":[{"given":"Yukiko","family":"Aikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Katsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Shino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Terui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Richard","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G","family":"Tenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issay","family":"Kitabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,25]]},"reference":[{"key":"BFnm2122_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet, D. & Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730\u2013737 (1997).","journal-title":"Nat. Med."},{"key":"BFnm2122_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya, T., Morrison, S.J., Clarke, M.F. & Weissman, I.L. Stem cells, cancer and cancer stem cells. Nature 414, 105\u2013111 (2001).","journal-title":"Nature"},{"key":"BFnm2122_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ng0996-33","volume":"14","author":"J Borrow","year":"1996","unstructured":"Borrow, J. et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14, 33\u201341 (1996).","journal-title":"Nat. Genet."},{"key":"BFnm2122_CR4","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1349-7006.2008.00865.x","volume":"99","author":"T Katsumoto","year":"2008","unstructured":"Katsumoto, T., Yoshida, N. & Kitabayashi, I. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis. Cancer Sci. 99, 1523\u20131527 (2008).","journal-title":"Cancer Sci."},{"key":"BFnm2122_CR5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1101\/gad.1393106","volume":"20","author":"T Katsumoto","year":"2006","unstructured":"Katsumoto, T. et al. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev. 20, 1321\u20131330 (2006).","journal-title":"Genes Dev."},{"key":"BFnm2122_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1101\/gad.1382606","volume":"20","author":"T Thomas","year":"2006","unstructured":"Thomas, T. et al. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. Genes Dev. 20, 1175\u20131186 (2006).","journal-title":"Genes Dev."},{"key":"BFnm2122_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","volume":"6","author":"BJ Huntly","year":"2004","unstructured":"Huntly, B.J. et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6, 587\u2013596 (2004).","journal-title":"Cancer Cell"},{"key":"BFnm2122_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1535-6108(03)00051-5","volume":"3","author":"K Deguchi","year":"2003","unstructured":"Deguchi, K. et al. MOZ-TIF2\u2013induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 3, 259\u2013271 (2003).","journal-title":"Cancer Cell"},{"key":"BFnm2122_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3324\/haematol.13020","volume":"93","author":"K Terui","year":"2008","unstructured":"Terui, K. et al. Two novel variants of MOZ-CBP fusion transcripts in spontaneously remitted infant leukemia with t(1;16;8)(p13;p13;p11), a new variant of t(8;16)(p11;p13). Haematologica 93, 1591\u20131593 (2008).","journal-title":"Haematologica"},{"key":"BFnm2122_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1189\/jlb.0903442","volume":"75","author":"SH Burnett","year":"2004","unstructured":"Burnett, S.H. et al. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J. Leukoc. Biol. 75, 612\u2013623 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"BFnm2122_CR11","doi-asserted-by":"publisher","first-page":"10677","DOI":"10.1158\/0008-5472.CAN-07-1118","volume":"67","author":"H Kawagoe","year":"2007","unstructured":"Kawagoe, H., Kandilci, A., Kranenburg, T.A. & Grosveld, G.C. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice. Cancer Res. 67, 10677\u201310685 (2007).","journal-title":"Cancer Res."},{"key":"BFnm2122_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1182\/blood.V99.1.111","volume":"99","author":"XM Dai","year":"2002","unstructured":"Dai, X.M. et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies and reproductive defects. Blood 99, 111\u2013120 (2002).","journal-title":"Blood"},{"key":"BFnm2122_CR13","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/1535-7163.MCT-05-0313","volume":"5","author":"H Ohno","year":"2006","unstructured":"Ohno, H. et al. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol. Cancer Ther. 5, 2634\u20132643 (2006).","journal-title":"Mol. Cancer Ther."},{"key":"BFnm2122_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.onc.1209007","volume":"25","author":"JR Taylor","year":"2006","unstructured":"Taylor, J.R., Brownlow, N., Domin, J. & Dibb, N.J. FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance. Oncogene 25, 147\u2013151 (2006).","journal-title":"Oncogene"},{"key":"BFnm2122_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4161\/cc.4.7.1788","volume":"4","author":"AL Dewar","year":"2005","unstructured":"Dewar, A.L., Zannettino, A.C., Hughes, T.P. & Lyons, A.B. Inhibition of c-fms by imatinib: expanding the spectrum of treatment. Cell Cycle 4, 851\u2013853 (2005).","journal-title":"Cell Cycle"},{"key":"BFnm2122_CR16","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1182\/blood-2004-10-3967","volume":"105","author":"AL Dewar","year":"2005","unstructured":"Dewar, A.L. et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 105, 3127\u20133132 (2005).","journal-title":"Blood"},{"key":"BFnm2122_CR17","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1128\/MCB.16.3.1231","volume":"16","author":"DE Zhang","year":"1996","unstructured":"Zhang, D.E. et al. CCAAT enhancer-binding protein (C\/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16, 1231\u20131240 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm2122_CR18","doi-asserted-by":"publisher","first-page":"7184","DOI":"10.1093\/emboj\/20.24.7184","volume":"20","author":"I Kitabayashi","year":"2001","unstructured":"Kitabayashi, I., Aikawa, Y., Nguyen, L.A., Yokoyama, A. & Ohki, M. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J. 20, 7184\u20137196 (2001).","journal-title":"EMBO J."},{"key":"BFnm2122_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/blood-2008-11-191890","volume":"114","author":"M Hoogenkamp","year":"2009","unstructured":"Hoogenkamp, M. et al. Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood 114, 299\u2013309 (2009).","journal-title":"Blood"},{"key":"BFnm2122_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S1074-7613(02)00452-1","volume":"17","author":"JC Walsh","year":"2002","unstructured":"Walsh, J.C. et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17, 665\u2013676 (2002).","journal-title":"Immunity"},{"key":"BFnm2122_CR21","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1093\/emboj\/17.13.3714","volume":"17","author":"E Kroon","year":"1998","unstructured":"Kroon, E. et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17, 3714\u20133725 (1998).","journal-title":"EMBO J."},{"key":"BFnm2122_CR22","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1182\/blood-2006-08-041202","volume":"109","author":"G Jin","year":"2007","unstructured":"Jin, G. et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood 109, 3998\u20134005 (2007).","journal-title":"Blood"},{"key":"BFnm2122_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jcp.1041350119","volume":"135","author":"C Wang","year":"1988","unstructured":"Wang, C. et al. Expression of the CSF-1 gene in the blast cells of acute myeloblastic leukemia: association with reduced growth capacity. J. Cell. Physiol. 135, 133\u2013138 (1988).","journal-title":"J. Cell. Physiol."},{"key":"BFnm2122_CR24","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1172\/JCI113413","volume":"81","author":"A Rambaldi","year":"1988","unstructured":"Rambaldi, A. et al. Expression of the macrophage colony\u2013stimulating factor and c-fms genes in human acute myeloblastic leukemia cells. J. Clin. Invest. 81, 1030\u20131035 (1988).","journal-title":"J. Clin. Invest."},{"key":"BFnm2122_CR25","first-page":"874","volume":"47","author":"HD Preisler","year":"1987","unstructured":"Preisler, H.D., Kinniburgh, A.J., Wei-Dong, G. & Khan, S. Expression of the protooncogenes c-myc, c-fos and c-fms in acute myelocytic leukemia at diagnosis and in remission. Cancer Res. 47, 874\u2013880 (1987).","journal-title":"Cancer Res."},{"key":"BFnm2122_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/329259a0","volume":"329","author":"S Gisselbrecht","year":"1987","unstructured":"Gisselbrecht, S. et al. Frequent c-fms activation by proviral insertion in mouse myeloblastic leukaemias. Nature 329, 259\u2013261 (1987).","journal-title":"Nature"},{"key":"BFnm2122_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0092-8674(87)90135-8","volume":"51","author":"JM Heard","year":"1987","unstructured":"Heard, J.M., Roussel, M.F., Rettenmier, C.W. & Sherr, C.J. Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogene. Cell 51, 663\u2013673 (1987).","journal-title":"Cell"},{"key":"BFnm2122_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/blood-2006-10-052282","volume":"110","author":"TL Gu","year":"2007","unstructured":"Gu, T.L. et al. A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia. Blood 110, 323\u2013333 (2007).","journal-title":"Blood"},{"key":"BFnm2122_CR29","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1182\/blood-2005-03-0860","volume":"106","author":"H Iwasaki","year":"2005","unstructured":"Iwasaki, H. et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590\u20131600 (2005).","journal-title":"Blood"},{"key":"BFnm2122_CR30","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1093\/nar\/gng012","volume":"31","author":"J Seibler","year":"2003","unstructured":"Seibler, J. et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 31, e12 (2003).","journal-title":"Nucleic Acids Res."},{"key":"BFnm2122_CR31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","volume":"7","author":"S Morita","year":"2000","unstructured":"Morita, S., Kojima, T. & Kitamura, T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063\u20131066 (2000).","journal-title":"Gene Ther."},{"key":"BFnm2122_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1128\/MCB.14.1.373","volume":"14","author":"DE Zhang","year":"1994","unstructured":"Zhang, D.E., Hetherington, C.J., Chen, H.M. & Tenen, D.G. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. Cell. Biol. 14, 373\u2013381 (1994).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm2122_CR33","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1128\/MCB.02422-06","volume":"27","author":"H Yoshida","year":"2007","unstructured":"Yoshida, H. et al. PML-retinoic acid receptor \u03b1 inhibits PML IV enhancement of PU.1-induced C\/EBP\u025b expression in myeloid differentiation. Mol. Cell. Biol. 27, 5819\u20135834 (2007).","journal-title":"Mol. Cell. Biol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2122","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:25:16Z","timestamp":1684448716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,25]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["BFnm2122"],"URL":"https:\/\/doi.org\/10.1038\/nm.2122","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,25]]}}}